Developing a new method for sampling carbon nanotubes in the air
Fiber sampling technique and counting protocol development for carbon nanotubes
This study is working on a better way to collect tiny fibers called carbon nanotubes from the air, which might be harmful to health, similar to asbestos, so we can understand their risks more clearly.
Quick facts
| Grant type | R21 grant |
|---|---|
| Study type | NIH-funded research |
| Funding institution | University of California Los Angeles NIH-funded |
| Lab location | 1 site (Los Angeles, United States) |
| Project ID | NIH-10914635 on NIH RePORTER |
What this research studies
This research focuses on creating an improved technique for sampling airborne carbon nanotubes (CNTs), which are tiny fibers that may pose health risks similar to asbestos. The team will investigate the surface properties of various CNTs and sampling filters to enhance efficiency. They will also develop a novel image analysis protocol and utilize a new nanoparticle isokinetic diffusion sampler to better understand how these particles behave in the air. The ultimate goal is to produce a reliable method for accurately sampling CNTs to assess potential health risks.
Who could benefit from this research
Good fit: Ideal candidates for this research would include individuals working in industries where exposure to carbon nanotubes is possible, such as manufacturing or construction.
Not a fit: Patients who are not exposed to carbon nanotubes or who do not work in related industries may not benefit from this research.
Why it matters
Potential benefit: If successful, this research could lead to more effective monitoring of carbon nanotube exposure, potentially reducing health risks associated with these materials.
How similar studies have performed: While there has been significant research on asbestos sampling methods, this approach to carbon nanotubes is relatively novel and untested.
Where this research is happening
Los Angeles, United States
- University of California Los Angeles — Los Angeles, United States (Active)
Researchers
- Principal investigator: Tsai, Candace Sujung — University of California Los Angeles
- Study coordinator: Tsai, Candace Sujung
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.